Gabriel Figueroa-Parra, MD, MSc

2.3K posts

Gabriel Figueroa-Parra, MD, MSc

@DrGabrielFP

Assistant Professor of Rheumatology @uanl | LUMEN Research Collaborator @mayoclinic | Tweets are my own / 🐘☕🩺📖 / Left-handed.

25.68597,-100.346851 Katılım Haziran 2009

1.5K Takip Edilen628 Takipçiler

Sabitlenmiş Tweet

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·3 Ağu

Scientific Oath 🙋🏻‍♂️ I promise to work for a better world, where science and technology are used in socially responsible ways. I will not use my education for any purpose intended to harm human beings or the environment... 1/2

English

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·4 Ara

@JoseMeadeMD @MayoPCCM Felicidades José!

Monterrey, Nuevo León 🇲🇽 Español

451

Jose A. Meade, MD@JoseMeadeMD·3 Ara

This a dream come true! Excited to join the @MayoPCCM team! 😍💙

English

197

32.8K

Gabriel Figueroa-Parra, MD, MSc retweetledi

Mithu Maheswaranathan, MD@MithuRheum·5 Kas

🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋 Just Released: Nov 3 #ACR25 🔥 🔸Review organ-specific treatment recommendations 🔸Steroid & HCQ Use Guidance ➠ Read the Full Guideline: acr.tw/47mkegj #RheumX #RheumTwitter #Rheum @RheumNow

English

118

322

32.3K

Gabriel Figueroa-Parra, MD, MSc retweetledi

ACR_Journals@ACR_Journals·3 Kas

Now published: The 2025 ACR Guideline for the Treatment of Systemic Lupus Erythematosus 📄 Read the paper: acr.tw/47mkegj ℹ️ See additional content and resources on this guideline at acr.tw/4mbHK4W

English

132

332

21.2K

Gabriel Figueroa-Parra, MD, MSc retweetledi

American College of Rheumatology@ACRheum·3 Kas

NEW! The ACR just released an updated clinical practice guideline for #SLE! Key recommendations include universal hydroxychloroquine use, lower steroid exposure, & earlier immunosuppressive therapy. Patient-centered care is central. READ MORE → acr.tw/4oAFS6q

American College of Rheumatology tweet media

English

1.1K

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·3 Kas

Great summary!

Gabriel Figueroa-Parra, MD, MSc tweet media

American College of Rheumatology@ACRheum

NEW ACR clinical practice guideline provides recommendations regarding treatment of systemic lupus erythematosus (SLE) in both adults and children. FULL GUIDELINE → acr.tw/4mbHK4W #SLE #lupus

Monterrey, Nuevo León 🇲🇽 English

114

Gabriel Figueroa-Parra, MD, MSc retweetledi

Jaime Flores-Gouyonnet, MD@JaimeFG_MD·28 Eki

Honored to present our work at #ACR25: “Differential Risk of Inpatient Admissions Among SLE Subgroups: A Population-Based Analysis.” Grateful to my mentor @AliDuarteMD and the LUMEN team for their outstanding collaboration and guidance. #Rheumatology #Lupus #LupusResearch

English

2.2K

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·27 Eki

Happy with my friend Mario Bautista, receiving the "Griffing-Nelson Award" during the Hench Society event for his outstanding abstract! All invited to the presentation #today at S102 (SLE abstracts) #ACR2025

Chicago, IL 🇺🇸 English

574

Gabriel Figueroa-Parra, MD, MSc retweetledi

American College of Rheumatology@ACRheum·22 Eki

Congratulations to Eric L. Matteson, MD, MPH, recipient of the 2025 Presidential Gold Medal Award! @MayoClinic #ACR25

English

2.5K

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·24 Eki

🚨🚨🚨

American College of Rheumatology@ACRheum

NEW #SLE clinical practice guideline to be unveiled at #ACR25! ✨ Don’t miss this important session—2025 American College of Rheumatology Guideline for the Treatment of Systemic Lupus Erythematosus, Saturday, Oct. 26, 9:00-10:30 AM CT. DETAILS → acr.tw/3WkE8SI COMING SOON: Full guideline manuscript. Stay tuned 👀 → acr.tw/43u8XGi

ART

Gabriel Figueroa-Parra, MD, MSc retweetledi

Circulation@CircAHA·17 Eyl

YAP1-CCN2 signaling enables proproliferative communication between microvascular ECs and vascular SMCs in patients with antiphospholipid syndrome (APS) vasculopathy. Inhibiting the pathway could lead to a targeted treatment approach @RayZuoMD @DrGabrielFP ahajournals.org/doi/full/10.11…

English

2.2K

Gabriel Figueroa-Parra, MD, MSc retweetledi

American College of Rheumatology@ACRheum·15 Eyl

#ACR25 abstracts now online! 🎉 Browse over 3,100 abstracts representing the highest-impact research in the field of #rheum. NOTE: Information that goes beyond that contained in the abstract is under media embargo until Oct. 25 at 10:00 AM CT. View 👀 → acr.tw/30RaIzl

English

2.5K

Gabriel Figueroa-Parra, MD, MSc retweetledi

American College of Rheumatology@ACRheum·2 Eyl

NEW EPISODE! Alain Sanchez-Rodriguez, MD, joins the podcast to discuss delays in #lupus diagnosis & care based on findings from the Lupus Midwest Network (LUMEN)🎙️LISTEN NOW → acr.tw/3UWKCXi @ACR_Journals

English

1.9K

Gabriel Figueroa-Parra, MD, MSc retweetledi

Alain Sanchez, MD@lain_sanchez·2 Eyl

Thanks so much for this opportunity!! sites.libsyn.com/436041/lumen

American College of Rheumatology@ACRheum

English

206

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·8 May

📢📢 Oficialmente, las guías 2024 del ACR para nefritis lúpica disponibles en extenso!!

ACR_Journals@ACR_Journals

Now published simultaneously in AC&R + A&R, the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis See ACR guideline page for resources - rheumatology.org/lupus-guideline DOI link - doi.org/10.1002/acr.25… Download the article - acr.tw/44sRwJM

Español

168

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·5 Nis

I wasn't expecting this! 😮 Shout-out to @MariaCuellarMD, @AliDuarteMD, and all the team!

English

446

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·26 Mar

📢📢📢Check out the new 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis!!! Now available online: acrjournals.onlinelibrary.wiley.com/doi/abs/10.100…

English

342

Gabriel Figueroa-Parra, MD, MSc retweetledi

Manuel Ugarte-Gil@mugartegil·9 Şub

🚨🆕paper: #hypertension predicts #global and #renal #damage in #SLE #lupus data from the #AlmenaraLupusCohort @cientifica_sur @EsSaludPeru @PanlarLeague published in @SageHealthInfo journals.sagepub.com/doi/10.1177/09…

English

591

Gabriel Figueroa-Parra, MD, MSc retweetledi

Jaime Flores-Gouyonnet, MD@JaimeFG_MD·28 Oca

🚨New Research Alert 🚨 Excited to share our latest study in @TheLancetRheum We analyzed the accuracy, quality, and safety of Large Language Models —ChatGPT-4, Claude 3: Opus and Gemini Advanced— in rheumatology board-like questions. Read more: thelancet.com/journals/lanrh…

English

Gabriel Figueroa-Parra, MD, MSc retweetledi

Jason S Knight@jasonsknight·22 Oca

Antiphospholipid Antibodies Linked to Increased Risk for Diffuse Alveolar Hemorrhage in SLE rheumatologyadvisor.com/news/apl-posit…

English

716

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·27 Ara

@lain_sanchez @JoseMeadeMD @marianagt95 @MariaCuellarMD @CDCChronic @MayoGradSchool @RochesterEpi

QAM

132

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·27 Ara

This study is derived from my master’s degree thesis. I would like to thank my mentors @AliDuarteMD, @CrowsonCindy, and my TAC: Matthew J. Koster, MD, @LadanZand, and @mugartegil. Also, thanks to all coauthors and funding sources that made this project possible.

English

204

Gabriel Figueroa-Parra, MD, MSc@DrGabrielFP·27 Ara

🧵 1/6 New research alert! 🚨 Our most recent LUMEN (💡) paper explores the utility of the 2019 EULAR/ACR SLE classification criteria in predicting mortality and hospitalization in patients with SLE. #LupusResearch #SLE. rmdopen.bmj.com/content/10/4/e…

English

1.8K

Keşfet

@JoseMeadeMD @MayoPCCM @RheumNow @AliDuarteMD @MayoClinic @RayZuoMD @ACR_Journals @MariaCuellarMD